Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 24:14:1272932.
doi: 10.3389/fendo.2023.1272932. eCollection 2023.

Editorial: Hormone resistance in cancer

John T Phoenix  1   2 , Audris Budreika  1 , Raymond J Kostlan  1   2 , Justin H Hwang  3 , Sean W Fanning  1 , Steven Kregel  1
Affiliations
Editorial

Editorial: Hormone resistance in cancer

John T Phoenix et al. Front Endocrinol (Lausanne). .
No abstract available

Keywords: breast; hormone signaling; lineage plasticity; neuroendocrine; nuclear hormone receptors; pituitary; prostate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Hormone–driven cancer progression to neuroendocrine phenotype.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Hormone resistance in cancer

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin (2023) 73:17–48. doi: 10.3322/caac.21763 - DOI - PubMed
    1. Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer (2007) 120:719–33. doi: 10.1002/ijc.22365 - DOI - PubMed
    1. Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, et al. . Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med (2012) 367:1187–97. doi: 10.1056/NEJMoa1207506 - DOI - PubMed
    1. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med (2006) 354:270–82. doi: 10.1056/NEJMra050776 - DOI - PubMed
    1. Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15–year survival: an overview of the randomised trials. Lancet (2005) 365:1687–717. doi: 10.1016/S0140-6736(05)66544-0 - DOI - PubMed

Publication types